<DOC>
	<DOCNO>NCT02834286</DOCNO>
	<brief_summary>The purpose study determine response rate response duration combination low-dose rituximab , eltrombopag high-dose dexamethasone .</brief_summary>
	<brief_title>Rituximab , Eltrombopag Dexamethasone Frontline Treatment Immune Thrombocytopenia</brief_title>
	<detailed_description>Immune thrombocytopenia autoimmune disorder characterize formation autoantibody platelet antigen lead platelet destruction . Corticosteroids increase platelet count 80 percent patient . However , many patient relapse dose corticosteroid reduce . Debilitating side effect common patient require long-term corticosteroid therapy maintain platelet count . Eltrombopag , small molecule agonist c-mpl ( TpoR ) receptor , physiological target hormone thrombopoietin , show effectively raise platelet count adult patient ( age 18 year ) spleen remove splenectomy option receive prior treatment corticosteroid immunoglobulin , medicine work ( refractory ITP ) . There case report eltrombopag option first line treatment IT . The purpose study determine response rate response duration combination rituximab ( 100 mg weekly four week ) , eltrombopag ( 50mg PO day , day 1-28 ) high-dose dexamethasone ( 40mg PO day 1-4 ) untreated adult patient &lt; 30*109/L platelet count diagnose immune thrombocytopenia . A complete response define increase platelet count &gt; 150×109/L two consecutive occasion . A clinical response define increase platelet count &gt; 30×109/L two consecutive measure bleed . Duration response consider day initial administration first time relapse ( platelet count &lt; 30×109/L ) time analysis Patients evaluate week 4 week every month least 6 month .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Clinically confirm immune thrombocytopenic ( IT ) Platelet count le 30,000/mm3 two ocasionts bleed . Subject ≥ 16 year Subject sign dated write informed consent . No sepsis fever active infection Not pregnant nurse Previous treatment ( corticosteroid dose prednisone equivalent 300 mg ) Performance status equal 2 . Pregnancy lactation Previous splenectomy Connective tissue disease Autoimmune hemolytic anemia Relapse</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>